OyaGen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OyaGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10912
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OyaGen Inc (OyaGen) is a biotechnology company that discovers, develops and commercializes novel pharmaceutical therapies. The company offers viral infectivity factor Dimerization Antagonist, Vif Interaction with APOBEC3G, Vif dependent polyubiquitination of APOBEC3G and APOBEC3G activators. It utilizes RNA editing and DNA editing enzymes to develop pharmaceutical therapies. OyaGen provides therapeutics for the treatment of diseases caused by human immunodeficiency virus. The company’s RNA editing and DNA editing enzymes are endogenous cellular proteins which chemically alter RNA or DNA molecules and change the genetic code. OyaGen is headquartered in Henrietta, New York, the US.

OyaGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OyaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OyaGen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
OyaGen Raises USD0.3 Million in Venture Financing 10
OyaGen Raises US$0.1 Million In Venture Financing 11
Oyagen Raises US$2 Million In Venture Financing 12
OyaGen Inc – Key Competitors 13
OyaGen Inc – Key Employees 14
OyaGen Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
OyaGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OyaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OyaGen Raises USD0.3 Million in Venture Financing 10
OyaGen Raises US$0.1 Million In Venture Financing 11
Oyagen Raises US$2 Million In Venture Financing 12
OyaGen Inc, Key Competitors 13
OyaGen Inc, Key Employees 14

List of Figures
OyaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[OyaGen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New York Power Authority:発電所・企業SWOT分析
    New York Power Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Tenaga Nasional Bhd (TENAGA):電力:M&Aディール及び事業提携情報
    Summary Tenaga Nasional Bhd (TNB) is an electricity utility that generates, transmits, distributes and supplies power. It develops, operates and maintains a portfolio of power generating units. The company produces electricity from crude oil, natural gas, hydro, coal and gas sources. TNB also suppli …
  • Chr. Hansen Holding AS (CHR):企業の財務・戦略的SWOT分析
    Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company that manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, insulin, injection, creams and gels, and solution …
  • Elanix Biotechnologies AG (ELN):製薬・医療:M&Aディール及び事業提携情報
    Summary Elanix Biotechnologies AG (Elanix Biotechnologies), formerly Porta Systems AG, is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological and gynecological applications. The company offers GYNrepair cream and SKINrepair cream for skin care …
  • ING Bank NV:企業のM&A・事業提携・投資動向
    ING Bank NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ING Bank NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Australian Agricultural Company Limited:企業の戦略・SWOT・財務分析
    Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • PCCW Limited:戦略・SWOT・企業財務分析
    PCCW Limited - Strategy, SWOT and Corporate Finance Report Summary PCCW Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Alps Electric Co., Ltd.:企業の戦略・SWOT・財務情報
    Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Porton Pharma Solutions Ltd (300363):企業の財務・戦略的SWOT分析
    Summary Porton Pharma Solutions Ltd (Porton) is involved in the supply of intermediate drugs and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It is also involved in providing research and development and produc …
  • KKR & Co. Inc:企業の戦略・SWOT・財務分析
    KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Genesis Energy Limited:企業の戦略・SWOT・財務分析
    Genesis Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Arab Orient Insurance Company:企業の戦略・SWOT・財務情報
    Arab Orient Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arab Orient Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務情報
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company's products pipeline includes CLBS03 is an autologous ex vivo p …
  • Schneider Electric SE (SU):企業の財務・戦略的SWOT分析
    Schneider Electric SE (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hexcel Corp (HXL):企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JXTG Holdings, Inc.:企業の戦略・SWOT・財務分析
    JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Federal Grid Company of Unified Energy System (FEES):企業の財務・戦略的SWOT分析
    Federal Grid Company of Unified Energy System (FEES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Isagen SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Isagen SA ESP (Isagen), a subsidiary of Brookfield Renewable Energy Partners LP, is an electricity utility. It generates and markets electricity; supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sources. Is …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆